142 related articles for article (PubMed ID: 3101072)
21. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
22. Influence of metiamide and atropine on acid and pepsin secretion in the anaesthetized Heidenhain cat.
Engler H; Beck H; Szelenyi I
Agents Actions; 1981 Apr; 11(1-2):164-7. PubMed ID: 6787848
[TBL] [Abstract][Full Text] [Related]
23. SC-29333: a potent inhibitor of canin gastric secretion.
Dajani EZ; Driskill DR; Bianchi RG; Collins PW; Pappo R
Am J Dig Dis; 1976 Dec; 21(12):1049-57. PubMed ID: 797257
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of nocturnal gastric secretion by trimoprostil, a synthetic prostanoid.
Penston J; Johnston DA; Wilson JA; Wormsley KG
Curr Med Res Opin; 1986; 10(3):145-9. PubMed ID: 3089691
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin increases the ratio between gastric mucosal blood flow and gastric acid and pepsin secretion in dogs.
Bech K
Scand J Gastroenterol; 1986 Mar; 21(2):215-20. PubMed ID: 2872716
[TBL] [Abstract][Full Text] [Related]
26. Are prostaglandins involved in somatostatin mediated inhibition of gastric secretion in the cat?
Albinus M; Frisch G
Agents Actions; 1986 Apr; 18(1-2):205-9. PubMed ID: 2873723
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
Gaginella TS; Müller RK; Witt CG; Rosen P; Holland GW; Gallo-Torres H; Sullivan AC
J Pharmacol Exp Ther; 1985 Jan; 232(1):202-7. PubMed ID: 2578188
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of canine gastric secretion by the prostanoid Ro 22-6923.
Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
Dig Dis Sci; 1985 Apr; 30(4):340-5. PubMed ID: 3979240
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of gastric inhibition by acidification of oxyntic gland area.
Konturek SJ; Obtulowicz W; Tasler J
J Physiol; 1975 Oct; 251(3):699-709. PubMed ID: 491
[TBL] [Abstract][Full Text] [Related]
30. Gastric bicarbonate secretion in humans. Effect of pentagastrin, bethanechol, and 11,16,16-trimethyl prostaglandin E2.
Feldman M
J Clin Invest; 1983 Jul; 72(1):295-303. PubMed ID: 6135708
[TBL] [Abstract][Full Text] [Related]
31. The effect of salbutamol and propranolol on pentagastrin, histamine and meal-stimulated acid and pepsin secretion in the dog.
McCloy RF; Dawson VA; Baron JH
Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):399-406. PubMed ID: 393041
[TBL] [Abstract][Full Text] [Related]
32. Central and peripheral effects of prostaglandin E2 and enprostil on gastric acid secretion in the rat.
Sautereau D; Chicau-Chovet M; Tsocas A; Rozé C
Eur J Pharmacol; 1991 Mar; 195(2):217-24. PubMed ID: 1678708
[TBL] [Abstract][Full Text] [Related]
33. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia.
Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE
Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653
[TBL] [Abstract][Full Text] [Related]
34. Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion.
Deakin M; Ramage J; Paul A; Gray SP; Billings J; Williams JG
Gut; 1986 Sep; 27(9):1054-7. PubMed ID: 3093317
[TBL] [Abstract][Full Text] [Related]
35. Effects of prostaglandin E2, 16,16-dimethyl prostaglandin E2 and a prostaglandin endoperoxide analogue (U-46619) on gastric secretory volume, [H+] and mucus synthesis and secretion in the rat.
Tao P; Wilson DE
Prostaglandins; 1984 Sep; 28(3):353-65. PubMed ID: 6595717
[TBL] [Abstract][Full Text] [Related]
36. Cholinergic and pentagastrin stimulation of the gastric secretions of acid, pepsin and lipase in the awake rabbit.
Perret JP; Daoud-Elbaba M; Rakotomalala H; Gros I; Descroix-Vagne M
Arch Int Physiol Biochim Biophys; 1993; 101(1):87-91. PubMed ID: 7684285
[TBL] [Abstract][Full Text] [Related]
37. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
38. Cytoprotective and antisecretory effects of 11-deoxy-13,14-didehydro-16(s)-methyl PGE2 methylester (FCE 20700).
Arrigoni C; Mizzotti B; Toti D; Faustini F; Ceserani R
Prostaglandins Leukot Med; 1984 Jul; 15(1):79-89. PubMed ID: 6591214
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of gastric acid secretion in the conscious dog by the mast-cell stabilizing agent, FPL 52694.
Canfield SP; Curwain BP
Br J Pharmacol; 1983 Sep; 80(1):27-32. PubMed ID: 6652372
[TBL] [Abstract][Full Text] [Related]
40. The effect of propranolol on insulin-stimulated gastric secretion in dogs.
Grabner P; Holian O; Kalahanis NG; Torma Grabner E; Bombeck CT; Nyhus LM
Scand J Gastroenterol; 1981; 16(8):1067-72. PubMed ID: 6801757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
